New England Research & Management Inc. lessened its holdings in shares of Morgan Stanley (NYSE:MS – Free Report) by 10.1% during the 4th quarter, HoldingsChannel reports. The fund owned 15,200 shares of the financial services provider’s stock after selling 1,700 shares during the period. New England Research & Management Inc.’s holdings in Morgan Stanley were worth $1,911,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. DGS Capital Management LLC grew its stake in Morgan Stanley by 1.8% during the 4th quarter. DGS Capital Management LLC now owns 4,408 shares of the financial services provider’s stock valued at $554,000 after acquiring an additional 77 shares in the last quarter. Perfromance Wealth Partners LLC grew its stake in Morgan Stanley by 2.7% during the 4th quarter. Perfromance Wealth Partners LLC now owns 3,004 shares of the financial services provider’s stock valued at $378,000 after acquiring an additional 78 shares in the last quarter. Sivia Capital Partners LLC grew its stake in Morgan Stanley by 3.3% during the 4th quarter. Sivia Capital Partners LLC now owns 2,748 shares of the financial services provider’s stock valued at $346,000 after acquiring an additional 87 shares in the last quarter. Cardinal Point Capital Management ULC grew its stake in Morgan Stanley by 3.5% during the 4th quarter. Cardinal Point Capital Management ULC now owns 2,697 shares of the financial services provider’s stock valued at $339,000 after acquiring an additional 90 shares in the last quarter. Finally, Mason & Associates Inc grew its stake in Morgan Stanley by 2.9% during the 4th quarter. Mason & Associates Inc now owns 3,177 shares of the financial services provider’s stock valued at $399,000 after acquiring an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 84.19% of the company’s stock.
Morgan Stanley Stock Up 0.2 %
Shares of MS stock opened at $138.77 on Thursday. Morgan Stanley has a 12 month low of $83.09 and a 12 month high of $141.48. The firm has a market cap of $223.56 billion, a PE ratio of 17.48, a price-to-earnings-growth ratio of 1.20 and a beta of 1.36. The stock has a 50 day moving average of $129.66 and a 200-day moving average of $115.51. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 3.14.
Morgan Stanley Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 31st will be given a dividend of $0.925 per share. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date of this dividend is Friday, January 31st. Morgan Stanley’s dividend payout ratio is presently 46.60%.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the company. Wells Fargo & Company raised Morgan Stanley from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $107.00 to $142.00 in a research note on Friday, November 15th. Keefe, Bruyette & Woods boosted their price target on Morgan Stanley from $138.00 to $145.00 and gave the company a “market perform” rating in a research note on Friday, January 17th. The Goldman Sachs Group boosted their price target on Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Citigroup boosted their price target on Morgan Stanley from $105.00 to $135.00 and gave the company a “neutral” rating in a research note on Monday, November 25th. Finally, UBS Group boosted their price target on Morgan Stanley from $130.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, January 21st. Eleven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Morgan Stanley currently has a consensus rating of “Hold” and an average target price of $131.27.
Insider Activity
In other Morgan Stanley news, CFO Raja Akram sold 17,500 shares of the company’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $136.01, for a total value of $2,380,175.00. Following the sale, the chief financial officer now directly owns 81,440 shares in the company, valued at $11,076,654.40. This represents a 17.69 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Eric F. Grossman sold 13,097 shares of the company’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $136.20, for a total value of $1,783,811.40. Following the completion of the sale, the insider now owns 197,444 shares in the company, valued at $26,891,872.80. This trade represents a 6.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by company insiders.
Morgan Stanley Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories
- Five stocks we like better than Morgan Stanley
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Rebuilding the Empire: Can Dollar General Rally in 2025?
- The 3 Best Retail Stocks to Shop for in August
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- What Does Downgrade Mean in Investing?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.